HK1247561A1 - 活化乳酸細菌的方法 - Google Patents

活化乳酸細菌的方法

Info

Publication number
HK1247561A1
HK1247561A1 HK18107030.7A HK18107030A HK1247561A1 HK 1247561 A1 HK1247561 A1 HK 1247561A1 HK 18107030 A HK18107030 A HK 18107030A HK 1247561 A1 HK1247561 A1 HK 1247561A1
Authority
HK
Hong Kong
Prior art keywords
lactic acid
acid bacteria
activating lactic
activating
bacteria
Prior art date
Application number
HK18107030.7A
Other languages
English (en)
Inventor
Staffan Strömberg
Eamonn Connolly
Stefan Roos
Original Assignee
Infant Bacterial Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infant Bacterial Therapeutics Ab filed Critical Infant Bacterial Therapeutics Ab
Publication of HK1247561A1 publication Critical patent/HK1247561A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
HK18107030.7A 2015-01-14 2018-05-30 活化乳酸細菌的方法 HK1247561A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562103201P 2015-01-14 2015-01-14
PCT/EP2016/050694 WO2016113363A1 (en) 2015-01-14 2016-01-14 A method of activating lactic acid bacteria

Publications (1)

Publication Number Publication Date
HK1247561A1 true HK1247561A1 (zh) 2018-09-28

Family

ID=55129894

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18107030.7A HK1247561A1 (zh) 2015-01-14 2018-05-30 活化乳酸細菌的方法

Country Status (17)

Country Link
US (1) US20170304376A1 (zh)
EP (1) EP3244903B1 (zh)
JP (1) JP6837442B2 (zh)
CN (1) CN107427461B (zh)
AU (1) AU2016208007B2 (zh)
BR (1) BR112017014192B1 (zh)
CA (1) CA2972963C (zh)
CL (1) CL2017001722A1 (zh)
CY (1) CY1126127T1 (zh)
ES (1) ES2952585T3 (zh)
HK (1) HK1247561A1 (zh)
HR (1) HRP20230639T1 (zh)
HU (1) HUE062482T2 (zh)
MX (1) MX2017009247A (zh)
PL (1) PL3244903T3 (zh)
RS (1) RS64392B1 (zh)
WO (1) WO2016113363A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019060661A1 (en) * 2017-09-22 2019-03-28 Iowa State University Research Foundation, Inc. PROBIOTIC COMPOSITIONS FOR THE PRODUCTION OF DOPAMINE
WO2020004933A1 (ko) * 2018-06-26 2020-01-02 씨제이제일제당 (주) 구연산염을 포함하는 유산균 동결 보호용 조성물
CN110320840B (zh) * 2019-07-11 2021-06-22 四川长虹网络科技有限责任公司 一种可降低物联网产品电池电量消耗的方法及系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3436581B2 (ja) * 1994-03-18 2003-08-11 雪印乳業株式会社 乳糖分解酵素活性の高い菌体の製造法
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
US20030017192A1 (en) * 2001-06-19 2003-01-23 Hanny Kanafani Process for producing extended shelf-life ready-to-use milk compositions containing probiotics
JP3957132B2 (ja) * 2001-09-07 2007-08-15 キッコーマン株式会社 低濁性醤油乳酸菌の分離用培地、同培地を用いる低濁性醤油乳酸菌の分離法及び同乳酸菌を用いる清澄度の高い醤油の製造法
FR2859217B1 (fr) * 2003-09-03 2005-11-11 Rhodia Chimie Sa Activateur pour ferment a base de bacteries lactiques et procede de preparation d'un produit mettant en oeuvre ledit activateur
JP2007330157A (ja) * 2006-06-15 2007-12-27 Obihiro Univ Of Agriculture & Veterinary Medicine 乳酸菌及び乳酸菌由来物の癌細胞増殖抑制作用および炎症性サイトカイン抑制作用を測定する方法
US8617537B2 (en) * 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
FR2967070B1 (fr) * 2010-11-05 2013-07-05 Oreal Acide gras monoinsature pour prevenir et/ou traiter les imperfections du teint de la peau
EP2408171A1 (en) * 2010-07-16 2012-01-18 Research In Motion Limited Application programming interface for mapping application
EP3335577A1 (en) * 2010-12-31 2018-06-20 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
JP5622110B2 (ja) * 2011-02-21 2014-11-12 株式会社農 新規乳酸菌
JP6051112B2 (ja) * 2013-06-05 2016-12-27 公立大学法人大阪府立大学 白金族金属の回収方法
CN104206539A (zh) * 2014-08-14 2014-12-17 澳优乳业(中国)有限公司 一种益生菌婴幼儿奶粉

Also Published As

Publication number Publication date
EP3244903B1 (en) 2023-06-07
EP3244903C0 (en) 2023-06-07
BR112017014192B1 (pt) 2022-02-01
AU2016208007B2 (en) 2021-09-09
AU2016208007A1 (en) 2017-07-06
JP6837442B2 (ja) 2021-03-03
US20170304376A1 (en) 2017-10-26
CN107427461A (zh) 2017-12-01
HUE062482T2 (hu) 2023-11-28
CN107427461B (zh) 2021-04-13
ES2952585T3 (es) 2023-11-02
CY1126127T1 (el) 2023-11-15
JP2018503684A (ja) 2018-02-08
PL3244903T3 (pl) 2023-08-14
EP3244903A1 (en) 2017-11-22
CA2972963C (en) 2023-03-14
CL2017001722A1 (es) 2018-04-06
BR112017014192A2 (pt) 2018-03-06
RS64392B1 (sr) 2023-08-31
CA2972963A1 (en) 2016-07-21
MX2017009247A (es) 2017-10-12
WO2016113363A1 (en) 2016-07-21
HRP20230639T1 (hr) 2023-09-29

Similar Documents

Publication Publication Date Title
HK1252568A1 (zh) 一種治療方法
DK3172315T3 (da) Fagresistente mælkesyrebakterier
PT3174988T (pt) Método para a preparação de ácido láctico
SG11201608272RA (en) Method for producing l-amino acids using an alkaliphilic bacteria
IL262149B (en) A method for producing lactic acid
PL3309254T3 (pl) Mikroorganizm wytwarzający kwas mlekowy i sposób wytwarzania kwasu mlekowego przy jego zastosowaniu
PL3001895T3 (pl) Prasa do belowania oraz sposób sterowania prasą do belowania
IL254530A0 (en) Preparation method of crystalline form a of pci-32765
GB201410116D0 (en) Method of treatment
PL2960326T3 (pl) Mikroorganizm zdolny do zwiększenia wytwarzania kwasu mlekowego i sposób wytwarzania kwasu mlekowego przy jego użyciu
IL253028A0 (en) treatment method
SG10201912688YA (en) A method of treatment
PL3160913T3 (pl) Sposób oczyszczania osadu biologicznego
SG11201609173YA (en) Method of producing nylon
HK1247561A1 (zh) 活化乳酸細菌的方法
SG11201701577WA (en) Lactic acid bacteria-containing composition
PT3497225T (pt) Método de produção de ácido láctico
SG11201605882TA (en) Method for culturing lactic acid bacteria at high concentration
HK1250243A1 (zh) 治療方法
PT3018198T (pt) Método de cultivar algas
GB201416909D0 (en) Method of forming concentrated solution
GB201416350D0 (en) A method of fitting
GB2555309B (en) A method of manufacturing a sterilized sachet
HK1249556A1 (zh) 乳酸菌的篩選方法
GB201504702D0 (en) Method of detecting bacteria